| Literature DB >> 12409633 |
Toshiya Tanaka1, Tetsu Takeno, Yuichiro Watanabe, Yasutoshi Uchiyama, Takeshi Murakami, Hisahiko Yamashita, Akifumi Suzuki, Rie Aoi, Hiroko Iwanari, Shu-Ying Jiang, Makoto Naito, Keisuke Tachibana, Takefumi Doi, Andrew I Shulman, David J Mangelsdorf, Raphael Reiter, Johan Auwerx, Takao Hamakubo, Tatsuhiko Kodama.
Abstract
Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins. In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion proteins as the immunizing agent. In this system, to display fusion proteins on the viral surface, the amino terminal sequences of human PPARd and PPARg2 are inserted in-frame between the signal sequence and the mature domain of the gp64 nucleotide sequence.Mabs were raised by immunization with whole virus without a purification of the target antigens. The Mabs generated by this novel method were shown to recognize not only the gp64-PPARs fusion protein, but also mature, expressed proteins by a wide variety of techniques, including immunohistochemistry, immunoblotting, and electrophoretic mobility shift assays (EMSAs). Transfection of the transfer vector containing a nucleotide sequence encoding less than 30 amino acids along with linearized baculovirus DNA allows for the production of a high affinity antibody against the corresponding mature form. This method is of potential utility in that it allows the production of valuable antibodies without the requirement of a protein purification step.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12409633 DOI: 10.5551/jat.9.233
Source DB: PubMed Journal: J Atheroscler Thromb ISSN: 1340-3478 Impact factor: 4.928